Risk of Hyponatremia and Associated Clinical Characteristics in Patients with Acute Lymphoblastic Leukemia after CD19 Targeted Chimeric Antigen Receptor (CAR) T-Cells

被引：0
|
作者：
Dixon, Brianne N.
Daley, Ryan J.
Horvat, Troy Z.
Buie, Larry W.
Hsu, Meier
Latcha, Sheron
Brentjens, Renier J.
Park, Jae H.
机构：
来源：
BLOOD | 2017年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3584
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Point of care CD19 chimeric antigen receptor (CAR) T-cells for relapsed/ refractory acute myeloid leukemia (AML) with aberrant CD19 antigen expression
    Danylesko, Ivetta
    Shem-Tov, Noga
    Yerushalmi, Ronit
    Jacoby, Elad
    Toren, Amos
    Shouval, Roni
    Itzhaki, Orit
    Avigdor, Abraham
    Shimoni, Avichai
    Nagler, Arnon
    CURRENT RESEARCH IN TRANSLATIONAL MEDICINE, 2024, 72 (04)
  • [2] CD19-targeted chimeric antigen receptor (CAR) T cells in CNS relapsed acute lymphoblastic leukemia (ALL).
    Newman, Haley
    Leahy, Allison Emily Barz
    Li, Yimei
    Liu, Hongyan
    Myers, Regina M.
    DiNofia, Amanda M.
    Dolan, Joseph Gregory
    Callahan, Colleen
    Devine, Kaitlin J.
    Wray, Lisa
    June, Carl H.
    Grupp, Stephan A.
    Rheingold, Susan R.
    Maude, Shannon L.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [3] Safety and efficacy of a humanized CD19 chimeric antigen receptor T cells for relapsed/refractory acute lymphoblastic leukemia
    Shi, Ming
    Li, Li
    Wang, Shiyuan
    Cheng, Hai
    Chen, Wei
    Sang, Wei
    Qi, Kunming
    Li, Zhenyu
    Wang, Gang
    Li, Huizhong
    Lan, Jianping
    Huang, Jinqi
    Fei, Xiaoming
    Yu, Min
    Li, Fei
    Qiao, Jianlin
    Wu, Qingyun
    Zeng, Lingyu
    Jing, Guangjun
    Zheng, Junnian
    Gale, Robert Peter
    Xu, Kailin
    Cao, Jiang
    AMERICAN JOURNAL OF HEMATOLOGY, 2022, 97 (06) : 711 - 718
  • [4] Novel CD19 chimeric antigen receptor T cells manufactured next-day for acute lymphoblastic leukemia
    Cheng Zhang
    Jiaping He
    Li Liu
    Jishi Wang
    Sanbin Wang
    Ligen Liu
    Jian Ge
    Lei Gao
    Li Gao
    Peiyan Kong
    Yao Liu
    Jia Liu
    Yu Han
    Yongliang Zhang
    Zhe Sun
    Xun Ye
    Wenjie Yin
    Martina Sersch
    Lianjun Shen
    Wei William Cao
    Xi Zhang
    Blood Cancer Journal, 12
  • [5] Novel CD19 chimeric antigen receptor T cells manufactured next-day for acute lymphoblastic leukemia
    Zhang, Cheng
    He, Jiaping
    Liu, Li
    Wang, Jishi
    Wang, Sanbin
    Liu, Ligen
    Ge, Jian
    Gao, Lei
    Gao, Li
    Kong, Peiyan
    Liu, Yao
    Liu, Jia
    Han, Yu
    Zhang, Yongliang
    Sun, Zhe
    Ye, Xun
    Yin, Wenjie
    Sersch, Martina
    Shen, Lianjun
    Cao, Wei William
    Zhang, Xi
    BLOOD CANCER JOURNAL, 2022, 12 (06)
  • [6] CHIMERIC ANTIGEN RECEPTOR (CAR) T CELLS TARGETING THE CD19 ANTIGEN FOR THE TREATMENT OF RELAPSED B CELL ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL)
    Curran, Kevin
    PEDIATRIC BLOOD & CANCER, 2014, 61 : S6 - S6
  • [7] Humanized CD19-targeted chimeric antigen receptor T (CAR-T) cells for relapsed/refractory pediatric acute lymphoblastic leukemia
    Wang, Shiyuan
    Wang, Xue
    Ye, Chunying
    Cheng, Hai
    Shi, Ming
    Chen, Wei
    Qi, Kunming
    Wang, Gang
    Wu, Qingyun
    Zeng, Lingyu
    Li, Zhenyu
    Jing, Guangjun
    Zheng, Junnian
    Xu, Kailin
    Cao, Jiang
    AMERICAN JOURNAL OF HEMATOLOGY, 2021, 96 (05) : E162 - E165
  • [8] The effect of pembrolizumab in combination with CD19-targeted chimeric antigen receptor (CAR) T cells in relapsed acute lymphoblastic leukemia (ALL)
    Maude, Shannon L.
    Hucks, George E.
    Self, Alix Eden
    Talekar, Mala Kiran
    Teachey, David T.
    Baniewicz, Diane
    Callahan, Colleen
    Gonzalez, Vanessa
    Nazimuddin, Farzana
    Gupta, Minna
    Frey, Noelle V.
    Porter, David L.
    Levine, Bruce L.
    Melenhorst, Jan J.
    Lacey, Simon F.
    June, Carl H.
    Grupp, Stephan A.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [9] Acute lymphoblastic leukemia relapse after CD19-targeted chimeric antigen receptor T cell therapy
    Wang, Jiasheng
    Hu, Yongxian
    Huang, He
    JOURNAL OF LEUKOCYTE BIOLOGY, 2017, 102 (06) : 1347 - 1356
  • [10] A retrospective comparison of CD19 single and CD19/CD22 bispecific targeted chimeric antigen receptor T cell therapy in patients with relapsed/refractory acute lymphoblastic leukemia
    Yiyun Wang
    Yingying Yang
    Ruimin Hong
    Houli Zhao
    Guoqing Wei
    Wenjun Wu
    Huijun Xu
    Jiazhen Cui
    Yanlei Zhang
    Alex H. Chang
    Yongxian Hu
    He Huang
    Blood Cancer Journal, 10
12345